Beximco has received the Food and Drug Administration’s blessing for Baclofen in dosage strengths of 10 and 20 mg tablets. The product is a muscle relaxant drug indicated for the treatment of muscle ...

Amneal is unveiling two generic products. The company is offering Lyvispah, a baclofen oral granules specialty product approved by the Food and Drug Administration for the treatment of spasticity ...

The approval was based upon a bioavailability study in healthy adults comparing baclofen oral tablets to Lyvispah. Amneal has announced the launch of Lyvispah ® (baclofen) oral granules for the ...

This was a randomized, between-subject, double-blind, placebo-controlled, human laboratory study conducted at the National Institutes of Health (NIH) Clinical Center in Bethesda, MD, from January 2013 ...

ST. PAUL, Minn.--(BUSINESS WIRE)-- Today, CNS Therapeutics announced the FDA approval of Gablofen® (baclofen injection) for use in the management of severe spasticity, giving healthcare providers a ...